In older mice, a drug called REGN1033 increases muscle size and maximum strength without changing the strength of individual muscle fibers.
See the scientific wording
In aged mice (19–24 months), administration of REGN1033 increases muscle mass by 11–12% and maximal isometric force by 16–18% without altering specific force, demonstrating that myostatin blockade enhances muscle quantity but not intrinsic fiber quality in aging.
Correlational — new studies may shift this
Randomized trialsOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Randomized Controlled TrialAnimal2015
In old mice, this drug makes muscles bigger and stronger overall by adding more muscle tissue, not by making each muscle fiber work harder — just like getting more bricks in a wall makes it stronger, not by making each brick stronger.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
A protein that normally stops muscle growth is blocked, allowing muscle fibers to build more protein and get bigger, which makes the whole muscle stronger without making each fiber stronger.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In older mice, a drug called REGN1033 increases muscle size and maximum strength without changing the strength of individual muscle fibers.
Mechanism
1 studyA natural brake on muscle growth is turned off, so muscle fibers get bigger by making more protein. Bigger fibers produce more total force, but each fiber's strength per size stays the same.
A protein that normally stops muscle growth is blocked, allowing muscle fibers to build more protein and get bigger, which makes the whole muscle stronger without making each fiber stronger.
A circulating inhibitory protein binds to and neutralizes myostatin in the bloodstream, preventing it from activating its receptor complex on muscle cells.
Inhibition of the receptor complex blocks phosphorylation of Smad2 and Smad3 proteins inside muscle cells.
Reduced Smad2/3 signaling removes suppression of muscle protein synthesis and prevents upregulation of genes that break down muscle proteins.
Muscle fibers increase their protein content, leading to larger cross-sectional area without changes in fiber type or number.
Increased muscle fiber size results in greater total force production during maximal contraction, while force per unit area remains unchanged.
Evidence from Studies
Supporting (1)
Community contributions welcome
Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
In old mice, this drug makes muscles bigger and stronger overall by adding more muscle tissue, not by making each muscle fiber work harder — just like getting more bricks in a wall makes it stronger, not by making each brick stronger.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Myostatin Inhibition on Muscle Mass and Force in Aged Murine Models
Systematic review and meta-analysis of all controlled studies in aged mice (19–24 months) treated with REGN1033 versus control, measuring muscle mass, maximal isometric force, and specific force as primary outcomes.
Double-Blind, Placebo-Controlled Trial of REGN1033 on Muscle Mass and Force in Aged Mice
Randomized, double-blind, placebo-controlled trial in aged mice (19–24 months) receiving REGN1033 versus vehicle control, with muscle mass, maximal isometric force, and specific force measured after a defined treatment period.
Longitudinal Cohort Study of REGN1033 Exposure and Muscle Outcomes in Aged Mice
Prospective cohort of aged mice (19–24 months) administered varying doses of REGN1033, with longitudinal measurements of muscle mass, maximal isometric force, and specific force over 12–24 weeks.
Mechanistic Study of REGN1033 on Muscle Fiber Quality in Aged Mice
Study in aged mice (19–24 months) treated with REGN1033, with muscle biopsies analyzed for fiber cross-sectional area, myosin content, and specific force to assess intrinsic quality.
In Vitro Analysis of REGN1033 on Myotube Hypertrophy and Contractile Protein Expression
Cultured myotubes from aged mice exposed to REGN1033, measuring changes in myotube diameter and specific force generation in isolated muscle fibers.